With Vaccine Approval Process Set to Change, FDA Advisers Leave Wiggle Room in Annual Covid-19 Shot Recommendations | News Channel 3-12
- The FDA's vaccine advisory panel met on Thursday, May 22, 2025, in the US to decide whether COVID-19 vaccines need strain updates for fall and winter shots.
- This meeting followed the FDA's recent policy shift limiting routine booster approval to seniors and high-risk individuals, requiring new trials for healthy younger people.
- Advisers voted unanimously to recommend targeting the JN.1 family of virus variants but allowed the FDA latitude to keep or update vaccine formulas.
- CDC data show 30,000 to 50,000 COVID-19 deaths since October, with boosters adding protection even for previously infected and vaccinated people, supported by Moderna's study involving 900,000 records.
- The decision implies continued vaccinations mainly for older adults and at-risk groups, while questions remain about vaccine access, coverage, and use among healthy younger people and infants.
16 Articles
16 Articles
FDA Panel Split on COVID-19 Booster Update Amid Policy Confusion
Government advisers were split Thursday on whether drugmakers need to update their COVID-19 vaccines for next season, a decision overshadowed by confusion over a new Trump administration policy that may limit which Americans can get the shots. The Food and Drug Administration’s outside experts have met annually since the launch of the first COVID-19 vaccines to discuss tweaking their recipes to stay ahead of the virus. The challenge is trying to…
San Diego doctors react to new FDA guidelines on COVID-19 shots
SAN DIEGO (FOX 5/KUSI) — The U.S. Food and Drug Administration is implementing more rigorous standards for approving future COVD-19 vaccines. The agency is no longer recommending universal boosters for everyone 6 months or older and will now take a more targeted approach, limiting its availability to seniors and those with pre-existing conditions that put them at a high-risk for severe illness. These new guidelines were published Tuesday in the …
FDA Advisers Recommend Updated COVID-19 Vaccines
Advisers to the Food and Drug Administration on May 22 recommended the agency direct COVID-19 vaccine manufacturers to update the strain their shots target. The Vaccines and Related Biological Products Advisory Committee unanimously voted to advise the regulator to have vaccines updated to target a single strain, one of the JN.1 subvariants. The Moderna and Pfizer vaccines currently contain formulations for the KP.2 strain, while Novavax’s vacci…
With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations | News Channel 3-12
By Brenda Goodman, CNN (CNN) — A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be included in this year’s Covid-19 vaccines, giving the agency latitude to keep the current shots or update its formulas to more closely match circulating viruses. Several of the committee members asked at Thursday’s meeti…


FDA Panel Recommends Monovalent COVID Vaccine for Next Season
(MedPage Today) -- An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 lineage, although members disagreed slightly about which specific strain should be included. "I'm...
Coverage Details
Bias Distribution
- 56% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage